NLRP3 and Parkinson disease: In LPS and 6‐OHDA‐induced PD models, caspase‐1 inhibitor Ac‐YVAD‐CMK could protect dopaminergic neurons by inhibiting NLRP3/caspase‐1/IL‐1β signaling pathway.